INVO Fertility (IVF) announced expanded clinical and embryology training support and improved pricing for its innovative INVOcell technology. This underscores the Company’s dual mission as an innovator of cutting-edge fertility solutions and a provider of compassionate, patient-centered clinical care through its established fertility clinics and is complementary to the Company’s focus on expanding its fertility clinic operations. The Company offers training to embryologists and physicians, including hands-on instruction and clinical support to ensure seamless integration of the INVOcell solution into clinical practices.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVF:
- INVO Fertility Amends Securities Purchase Agreement
- INVO Fertility adds PRP therapy capabilities to Wisconsin Fertility Institute
- INVO Fertility Adjourns Meeting to Solicit Votes
- INVO Fertility receives notice of allowance for modified INVOcell device patent
- INVO Fertility recommends shareholders vote for all proposals at Annual Meeting